The struggle to control the spread of tuberculosis (TB) in India looked like a hopeless cause ten years ago. The disease was killing so many people, without anyone noticing, every hour, and these deaths were happening more frequently in the most impoverished and vulnerable communities. The infected millions were caught in the vicious circle of cough, fever, weakness, stigma, and poverty.
However, the situation in the country at that time has completely changed, as India is now at a historic turning point in 2025. The World Health Organization (WHO) Global TB Report 2025 corroborates this by revealing that the country has achieved a phenomenal 21% reduction in tuberculosis incidence within a decade, which corresponds to the decrease of the rate from 237 to 187 cases per lakh population.
India, however, still remains that big elephant in the room as the country is responsible for 25% of the world’s new TB cases. The figures suggest far more than statistics—they symbolize the wins of human lives, the changes in systems, and the endurance of collective spirit.
Tuberculosis was one of the major healthcare challenges that India had been grappling with for years. Several factors, such as overcrowded slums, malnutrition, unsafe living conditions, and lack of awareness, contributed to the spread of the disease. People who lived in rural areas usually underestimated the symptoms of a chronic cough and weakness and did not suspect it could be tuberculosis. A large portion of them shunned diagnosis due to anxiety about being ostracized and losing their working days.
Also, the health sector was not performing well either and only recently very few changes could be noticed in the situation. There was and still is a network of manual reporting, difficult-to-reach testing locations, and insufficient follow-up systems. India’s TB situation got worse due to a combination of factors that included the stigma and neglect surrounding the disease, as well as the emergence of drug-resistant strains that made the treatment lengthy and expensive.
This was the India of the mid-2010s—a nation fighting an invisible enemy with blunt tools.
The change was brought about by the government’s decision to implement the TB Mukt Bharat Abhiyan campaign in accordance with the aim of eradicating tuberculosis by 2025, which is five years earlier than the global goal. The way the problem was tackled was radically changed as the emphasis was shifted from passive detection to actively going out to people. Medical personnel went from one household to another, carrying out their work with the help of portable digital gadgets and mobile applications, to find the “missing” TB patients who had previously evaded detection because they were in hard-to-reach areas or the system had overlooked them.
At the same time, the introduction of the new diagnostic methods such as molecular tests and digital chest X-rays, shortened the period for confirmation of the results from a few weeks to just a few hours. Delivering nutritional support through the Nikshay Poshan Yojana that provides patients with a monthly cash incentive was a smart move in ensuring that even the poorest of the poor would still be able to follow their treatment protocols and complete their regimens.
The World Health Organization (WHO) and other international partners including the Global Fund have been instrumental in invigorating India’s anti-TB campaign. They facilitated the training of frontline workers, opened up the drug supply chain, and allowed for continued diagnostics when the pandemic period caused progress to almost come to a halt.
Because of the actions that were taken to involve the community in the fight against the disease, and the publicity through digital means, the secrecy and shame that were associated with TB began to dissipate. Apart from that, religious leaders, local NGOs, and even schoolchildren became the advocates of awareness—encouraging people to take an early test and complete the full courses of treatment.
The document states that the coverage of the treatment in India increased from 53% in 2015 to more than 92% in 2024, with 26.18 lakh patients diagnosed out of the 27 lakh cases that have been estimated. In fact, this is a good indicator in terms of fewer missing patients, fewer broken families, and more survivors returning to normal lives.
Moreover, the 90% success rate for the treatment is as good as it can get, and this rate is now slightly above the global average of 88%. In addition, it is very important to note that there has been no significant increase in the number of multidrug-resistant TB (MDR-TB) cases, which is an indication that India’s measures toward early detection and strict adherence to drug regimes are producing the desired results.
India’s tuberculosis struggle is not over. However, it has undergone a profound transformation. The country, formerly dubbed as the “world’s TB capital,” has now become a beacon of what political determination, scientific breakthroughs, and community empowerment can collectively achieve.
While others are still striving to meet the target of “End TB by 2030,” India’s experience tells the world this is attainable through persistence, compassion, and accountability—that even the oldest diseases can be defeated eventually. The fight against TB is not only about eliminating infection; it is also about giving back dignity, strengthening resilience, and renewing faith in a better future.
